期刊文献+

用孕妇体重校正唐氏筛查的血清标志物中位数倍数 被引量:5

Multiple of the median correction of Down's syndrome serum markers with pregnant body weight
原文传递
导出
摘要 目的应用孕妇体重对早、中孕期整合筛查唐氏综合征(DS)的血清标志物中位数倍数(MoM)进行校正,降低假阳性率。方法同一个孕妇分别于孕11~13周+6d和15~20周+6d用无菌真空采血管采取静脉血,采用时间分辨免疫荧光法(DELFIA)检测甲胎蛋白(AFP)、游离-β亚基-促绒毛膜性腺激素(Free—BhcG)、妊娠相关血浆蛋白A(PAPP—A)等3种血清标志物筛查指标,利用筛查风险评估软件,计算血清标志物的MoM,对7997例本地孕妇进行DS的风险评估,用非线性加权回归法,构建本地人群的体重方程,应用孕妇体重对本地人群的血清标志物MoM进行校正。比较校正前后各筛查指标MoM的变化情况,x2检验比较检出率和假阳性率。结果AFP、Free-βhCG、PAPP—A的MoM值随体重增加而减少,筛查指标MoM经体重方程校正后,人群筛查的假阳性率由4.12%减少到3.86%(x2=0.021,P〉0.05)。设定临界值(cut—off值)为1/270,本地人群体重方程校正前后检出率均为71.4%。结论孕妇体重对Ds筛查的结果有影响,为了得到精确的风险计算结果,筛查时建议建立、并用孕妇体重校正本地区血清标志物中位数倍数。 Objective With Pregnant women weight correction for serum marker Multiple of Median (MoM) of First trimester and second-trimester, integrated screen-ing for Down's syndrome (DS), can reduce the false positive rate. Methods The same pregnant woman were taken venous blood vessels with sterile vacuum during the first trimester ( 11-13 W ( + 6) d) and the second trimester ( 15-20 W ( + 6) d), Alpha-fetoprotein (AFP) , serum free beta-human chorionic gonadotrophin (Free beta hCG) and pregnancy- associated protein-A (PAPP-A) of three kinds of serum marker screening indicators were assayed by Using Time-resolved fluoroimmunoassay (TRFIA). Screening for risk assessment software was used to calculate serum marker Multiple of Median, To assess the risks of 7 997 cases of local pregnant women DS, To construct the weight equation of local population using nonlinear weighted regression method, With maternal weight correction for serum marker Multiple of Median (MoM) of local pregnant women, Comparing the changes of screening index MoM before and after correction, chi square test to compare the detection rate and false positive rate. Results MoM values of three kinds of serum markers ( al-pha-fetoprotein, free beta subunit of human chorionic gonadotropin, pregnan-cy-associated plasma protein A) decreased with the weight increasing, Screening index MoM after correction weight equation, the screening of false positives for crowd from 4. 12% down to 3.86% (X2 =0. 021 ,P 〉0. 05). Setting threshold (cut-off) at 1/270, and no change detection rates were 71.4% the local population before and after correction weight equation. Conclusion Maternal weight may affect the results of Down's syn-drome screening. When screening proposal to set up, it is worth making weight cor-rections for serum maker multiple of median in order to get accurate risk calculation results.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第1期46-49,共4页 Chinese Journal of Laboratory Medicine
基金 基金项目:浙江省卫生厅A类基金(2008A154)
关键词 唐氏综合征 产前诊断 生物学标记 孕妇 体重 Down syndrome Prenatal diagnosis Biological markers Pregnant women Body weight
  • 相关文献

参考文献13

  • 1鲍培忠,吴亚农,顾青,洪庆,沈时霖.母血清标记物用于胎儿先天愚型的产前筛查[J].中华医学遗传学杂志,1998,15(5):320-321. 被引量:15
  • 2苗正友,刘霞,石统昆,葛嘉美,徐营.早、中孕期整合筛查唐氏综合征[J].中华医学杂志,2011,91(3):185-188. 被引量:16
  • 3Spencer K,Bindra R,Nicolaides KH. Maternal weight correction of maternal serum PAPP-A and free β-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy[J].Prenatal Diagnosis,2003.851-855.
  • 4Hsu J J,Hsieh TT,Hsieh FJ. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG:a report of the Taiwan Down Syndrome Screening Group[J].Obstetrics & Gynecology,1996.943-947.
  • 5Palomaki GE,Bradley LA,McDowell GA. Technical standards and guidelines:prenatal screening for Down Syndrome[J].GENETICS IN MEDICINE,2005.344-354.
  • 6吕时铭,沈凤贤.产前筛查与诊断的质量控制与热点问题[J].中华检验医学杂志,2013,36(1):1-5. 被引量:44
  • 7Krantz DA,Hallahan TW,Macri V J. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program[J].Prenatal Diagnosis,2005.635-640.
  • 8Crossley JA,Aitken DA,Waugh SML. Maternal smoking:age distribution,levels of alpha-fetoprotein and human chorionic gonadotrophin,and effect on detection of Down syndrome pregnancies in second-trimester screening[J].Prenatal Diagnosis,2002.247-255.
  • 9Spencer K,Heath V,El-Sheikhah A. Ethnicity and the need for correction of bio-chemical and ultrasound markers of chromosomal anomalies in the first trimester:a study of Oriental,Asian and Afro-Caribbean popu-lations[J].Prenatal Diagnosis,2005.365-369.
  • 10Spencer K,Cowans NJ,Spencer CE. A re-evaluation of the influence of maternal insulin-dependent diabetes on fetal nuchal translucency thickness and first-trimester maternal serum biochemical markers of aneuploidy[J].Prenatal Diagnosis,2010.937-940.

二级参考文献12

  • 1Merkatz IR,Nitowski HM,Macri JN,et al.An association between low maternal serum r-fetoprotein and fetal chromesome abnormalities.Am J Obstet Gynecol,1984,148:886.
  • 2Knight GJ,Palomarki GE,Haddow JE.Use of maternal serum α-fetaprotein measurements to screen for Down syndrome.Clin Obstet Gynecol,1988,31:36-39.
  • 3Okun N,Summers AM,Hoffman B,et al.Prospective experience with integrated prenatal screening and First-trimester combined screening for trisomy 21 in a large Canadian urban center.Prenat Diagn,2008,28:987-992.
  • 4Cicero S,Bindra R,Remboukos G,et al.Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency,absent fetal nasal bone,free beta-hCG and PAPP-A at 11 to 14 weeks.Prenat Diagn,2003,23:306-310.
  • 5Wapner R,Thom E,Simpson JL,et al.First-trimeste screening for trisomy 21 and 18.N Engl J Med,2003,349:1405-1413.
  • 6Malone FD,Canick JA,Ball RH,et al.First-trimester or secondtrimester screening,or both,for Down's syndrome.N Engl J Med,2005,353:2001-2011.
  • 7Borrceell A.Promises and pilfalls of First-trimester songraphic markers in the detection of fetal aneuploidy.Prenat Diagn,2009,29:62-68.
  • 8Vadiveloo T,Crossleg JA,Aitken DA.First-trimester contingent screening for Down's syndrome can reduce the number of nuchal transluliency measure meats required.Prenat Diagn,2009,29:79-82.
  • 9Permi SC,Predanic M,Kalish RB,et al.Clinical use of Firsttrimester aneuploidy screening in a united states population can replicate data from clinical trials.Am J Obstet Gynecol,2006,194:127-130.
  • 10Wald NJ,Watt HC,Hackshaw AK.Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.N Engl J Med,1999,341:461-467.

共引文献69

同被引文献55

  • 1朱宝生,边旭明.“中孕期母血清学产前筛查技术标准”解读[J].中国产前诊断杂志(电子版),2012,4(4):1-5. 被引量:9
  • 2康媛,马端,李笑天.唐氏综合征的产前筛查[J].中国产前诊断杂志(电子版),2008(1):40-43. 被引量:2
  • 3梁启峰.妊娠相关血浆蛋白-A与妊娠关系[J].广东医学,2006,27(12):1863-1865. 被引量:1
  • 4Nix B, Wright D, Baker A. The impact of bias in MoM values on patient risk and screening performance for Down syndrome[J]. Prenat Diagn, 2007, 27(9): 840-845.
  • 5Reynolds TM, Vranken G, Van Nueten J, et al. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis- derived parameters[J]. Int J Clin Pract, 2008, 62(5): 735-743.
  • 6中华人民共和国国家卫生和计划生育委员会.中华人民共和国卫生行业标准——ws322.1—2010胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准第1部分:中孕期母血清学产前筛查[s].2010.
  • 7Palomaki GE, Bradley LA, McDowell GA, et al. Technical standards and guidelines: Prenatal screening for Down syndrome [J]. Genet Med, 2005, 7(5): 344-354.
  • 8Matheus JI, Hamillon BE.Mean age of mather, 1970 ~ 2000[J]. Nath vital Stat Rep, 2002,51 :-13.
  • 9Merkatz IR, Nitowski HM, Macri JN, et al. An association between low maternal serum r-fetoprotein and fetal chromesome abnorrnalities[J].Am J Obstet Gynecol, 1984, 148:886.
  • 10Knight OJ, Palomarki GE, Haddow JE.Use of maternal serum ct-fctaprotein measurements to screen for Down syndrome[J].Clin Obstet Gynecol, 1988,31:36-39.

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部